BEZAFIBRATE



NAME OF DRUG : BEZAFIBRATE

ALSO KNOWN AS : BEZAFIBRATE

LABORATORY : INTERCEPT

STATUS AND ADVANCEMENT

Type of drug : tri PPAR alpha delta gamma

Clinical trials advancement : Initiating Phase 2a

Estimated time to market : 129 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON BEZAFIBRATE

SOME PUBLICATIONS RELATED WITH BEZAFIBRATE

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH BEZAFIBRATE


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE